Clinical Trials Directory

Trials / Completed

CompletedNCT05990972

Clinical Study of Fecal Microbiota Transplantation in the Treatment of Antibiotic-associated Diarrhea

To Investigate the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in the Treatment of Antibiotic-associated Diarrhea.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
21 Years – 78 Years
Healthy volunteers
Not accepted

Summary

Antibiotic-associated diarrhea (AAD) refers to the occurrence of other unexplained diarrhea symptoms after the use of antibiotics, often combined with abdominal pain, bloating and bloody stool. Fecal Microbiota Transplantation (FMT) is a therapeutic method to transplant the microbiota from the feces of healthy people into the intestinal tract of patients. To explore the overall efficacy and safety of FMT in the treatment of AAD.

Conditions

Interventions

TypeNameDescription
PROCEDUREFecal Microbiota TransplantationFecal Microbiota Transplantation (FMT) is a therapeutic method to transplant the microbiota from the feces of healthy people into the intestinal tract of patients. This treatment aims to improve a range of diseases associated with the gut microbiota by restoring the balance of the gut microbiota.

Timeline

Start date
2020-07-20
Primary completion
2023-04-20
Completion
2023-07-20
First posted
2023-08-14
Last updated
2023-08-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05990972. Inclusion in this directory is not an endorsement.

Clinical Study of Fecal Microbiota Transplantation in the Treatment of Antibiotic-associated Diarrhea (NCT05990972) · Clinical Trials Directory